Gepotidacin, a new first-in-class antibiotic for treating uncomplicated urinary tract infection

Lancet. 2024 Feb 24;403(10428):702-703. doi: 10.1016/S0140-6736(23)02697-1. Epub 2024 Feb 8.

Authors

Ased S M Ali¹, Catriona S Anderson²

Affiliations

¹ Department of Urology, Mid Yorkshire Teaching NHS Trust, Wakefield WF1 4DG, UK; Convatec, Deeside, UK. Electronic address: ased.ali@nhs.net.
² Longton Hall Surgery, NHS Primary Care Centre, Stoke on Trent, UK; Focus Medical Diagnostics, Newcastle under Lyme, UK.

PMID: 38342129
DOI: 10.1016/S0140-6736(23)02697-1

No abstract available

MeSH terms

Acenaphthenes
Anti-Bacterial Agents* / therapeutic use
Heterocyclic Compounds, 3-Ring
Humans
Urinary Tract Infections* / drug therapy

Substances

Anti-Bacterial Agents
gepotidacin
Acenaphthenes
Heterocyclic Compounds, 3-Ring